NASDAQ · Biotechnology

QURE (QURE) Stock

$43.63 +3.41% NASDAQ: QURE Healthcare

Valuation

MetricValue
Price$43.63
Market Cap$3.03B
P/E Ratio-11.42
P/B Ratio8.72
P/S Ratio96.97
EPS (TTM)$-2.48
52-Week High$71.50
52-Week Low$8.73
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-228.24%
ROA-16.98%
ROCE-94.47%
Gross Margin74.14%
Operating Margin-10.57%
Net Margin-11.54%
Debt/Equity0.42
Current Ratio10.41

Annual Financials (USD)

Metric20212022202320242025
Revenue$524.0M$106.0M$16.0M$27.0M$16.0M
Operating Profit$311.0M$-143.0M$-283.0M$-184.0M$-188.0M
Net Profit$330.0M$-127.0M$-308.0M$-240.0M$-199.0M
EPS$7.04$-2.71$-6.47$-4.92$-3.46
Op Margin59.3%-134.4%-1785.5%-679.6%-1166.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$809.0M$705.0M$832.0M$557.0M$825.0M
Total Liabilities$213.0M$229.0M$624.0M$563.0M$626.0M
Cash$556.0M$228.0M$241.0M$159.0M$80.0M
Borrowings$136.0M$143.0M$138.0M$66.0M$537.0M

Latest News

Uniqure Insider Sold Shares Worth $952,051, According to a Recent SEC Filing MT Newswires · Jul 7, 2026 Uniqure Insider Sold Shares Worth $983,030, According to a Recent SEC Filing MT Newswires · Jul 2, 2026 uniQure (QURE) Now Trades Above Golden Cross: Time to Buy? Zacks · Jul 1, 2026 XBI Ignored The Market's Downturn Trefis · Jun 29, 2026 UniQure Closes $259 Million Stock Offering MT Newswires · Jun 25, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$288.0M$-145.0M$-146.0M$-183.0M$-178.0M
Investing Cash Flow$-85.0M$-200.0M$-213.0M$160.0M$-322.0M
Financing Cash Flow$-1.0M$0$-8.0M$-9.0M$23.0M
Net Cash Flow$312.0M$-328.0M$13.0M$-84.0M$-79.0M
Free Cash Flow$271.0M$-163.0M$-153.0M$-186.0M$-178.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-67.40
EV / EBITDA-9.71
FCF Yield-9.81%
Quick Ratio10.40
Interest Coverage-3.03
Return 1Y183.37%
Return 3Y302.99%
Return 5Y55.25%

Ownership

Insiders Held1.29%
Institutions Held90.20%
Institutions Float Held91.38%
Institutional HolderSharesReport Date
Avoro Capital Advisors LLC5,959,5952026-03-31
Aberdeen Group plc5,306,3862026-03-31
JPMORGAN CHASE & CO2,837,4662026-03-31
Two Sigma Investments, LP2,675,8712026-03-31
RTW Investments LP2,586,3562026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ABCL $6.93 +6.13% -5.91 $2.12B 0.00%
CLDX $35.80 +0.63% -7.84 $2.38B 0.00%
EWTX $43.52 -2.03% -14.63 $4.68B 0.00%
GLPGGalapagos N.V. $27.98 +1.71% 3.57 $1.84B 0.00%
GPCRStructure Therapeutics Inc. $53.36 -3.23% -20.21 $3.07B 0.00%

About QURE

QURE is led by CEO Matthew Craig Kapusta, employs 209 people, headquartered in US, publicly traded since 2014.

QURE stock trades at $43.63 with a market capitalization of $3.03B. The stock is valued at a price-to-earnings (P/E) ratio of -11.42, price-to-book of 8.72, price-to-sales of 96.97. Over the past 52 weeks the stock has ranged between $8.73 and $71.50, and currently trades 39.0% below its 52-week high.

On profitability, QURE generates a return on equity (ROE) of -228.24%, return on capital employed of -94.47%, an operating margin of -10.57%, a net profit margin of -11.54%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides